Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription


1 Am J Epidemiol
1 Am J Surg
1 BMC Cancer
1 Breast Cancer Res
3 Breast Cancer Res Treat
3 Cancer
1 Cancer Cell
1 Cancer Chemother Pharmacol
1 Cancer Epidemiol Biomarkers Prev
2 Cancer Lett
3 Clin Breast Cancer
4 Eur J Cancer
1 Eur Radiol
1 Exp Cell Res
1 Gene
2 Int J Cancer
1 J Clin Invest
1 J Clin Oncol
1 J Pathol
2 Lancet Oncol
1 Nat Rev Clin Oncol
1 Oncogene
1 PLoS Comput Biol
3 PLoS One

    Am J Epidemiol

  1. GARCIA E, Bradshaw PT, Eisen EA
    Breast Cancer Incidence and Metalworking Fluid Exposure in a Cohort of Female Autoworkers.
    Am J Epidemiol. 2017 Aug 23. doi: 10.1093.
    >> Share

    Am J Surg

    Discussion of Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
    Am J Surg. 2017 Sep 30. pii: S0002-9610(17)31379.
    >> Share

    BMC Cancer

  3. LYSZCZARZ B, Nojszewska E
    Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014.
    BMC Cancer. 2017;17:676.
    >> Share

    Breast Cancer Res

  4. BERNHARDT S, Bayerlova M, Vetter M, Wachter A, et al
    Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
    Breast Cancer Res. 2017;19:112.
    >> Share

    Breast Cancer Res Treat

    Duration of trastuzumab in HER2-positive metastatic breast cancer after complete remission: still debatable issue?
    Breast Cancer Res Treat. 2017 Oct 11. doi: 10.1007/s10549-017-4536.
    >> Share

  6. DOMINICI LS, Sineshaw HM, Jemal A, Lin CC, et al
    Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt.
    Breast Cancer Res Treat. 2017 Oct 9. doi: 10.1007/s10549-017-4528.
    >> Share

  7. PAGE DB, Wen H, Brogi E, Dure D, et al
    Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impact.
    Breast Cancer Res Treat. 2017 Oct 6. doi: 10.1007/s10549-017-4520.
    >> Share


  8. JAGSI R, Abrahamse PH, Lee KL, Wallner LP, et al
    Treatment decisions and employment of breast cancer patients: Results of a population-based survey.
    Cancer. 2017 Oct 9. doi: 10.1002/cncr.30959.
    >> Share

  9. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
    Psychological distress associated with cancer screening: A systematic review.
    Cancer. 2017;123:3882-3894.
    >> Share

  10. DONALDSON AR, McCarthy C, Goraya S, Pederson HJ, et al
    Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsy.
    Cancer. 2017 Oct 10. doi: 10.1002/cncr.31061.
    >> Share

    Cancer Cell

  11. GULLUNI F, Martini M, De Santis MC, Campa CC, et al
    Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2alpha Scaffolding Function.
    Cancer Cell. 2017;32:444-459.
    >> Share

    Cancer Chemother Pharmacol

  12. LI C, Wang B, Chen SC, Wada R, et al
    Exposure-response analyses of trastuzumab emtansine in patients with HER2-positive advanced breast cancer previously treated with trastuzumab and a taxane.
    Cancer Chemother Pharmacol. 2017 Oct 11. doi: 10.1007/s00280-017-3440.
    >> Share

    Cancer Epidemiol Biomarkers Prev

  13. SHIYANBOLA OO, Arao RF, Miglioretti DL, Sprague BL, et al
    Emerging Trends in Family History of Breast Cancer and Associated Risk.
    Cancer Epidemiol Biomarkers Prev. 2017 Oct 6. pii: cebp.0531.2017.
    >> Share

    Cancer Lett

  14. SOHN EJ, Jung DB, Lee H, Han I, et al
    CNOT2 promotes proliferation and angiogenesis via VEGF signaling in MDA-MB-231 breast cancer cells.
    Cancer Lett. 2017 Oct 9. pii: S0304-3835(17)30621.
    >> Share

  15. WILMANSKI T, Zhou X, Zheng W, Shinde A, et al
    Inhibition of Pyruvate Carboxylase by 1alpha,25-Dihydroxyvitamin D Promotes Oxidative Stress in Early Breast Cancer Progression.
    Cancer Lett. 2017 Oct 9. pii: S0304-3835(17)30606.
    >> Share

    Clin Breast Cancer

  16. OBERGUGGENBERGER A, Meraner V, Sztankay M, Hilbert A, et al
    Health Behavior and Quality of Life Outcome in Breast Cancer Survivors: Prevalence Rates and Predictors.
    Clin Breast Cancer. 2017 Sep 18. pii: S1526-8209(17)30454.
    >> Share

  17. AKIMOTO E, Kadoya T, Kajitani K, Emi A, et al
    Role of 18F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30037.
    >> Share

  18. ROGOZ B, Houze de l'Aulnoit A, Duhamel A, Houze de l'Aulnoit D, et al
    Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer-A Single Institution Experience.
    Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(16)30427.
    >> Share

    Eur J Cancer

  19. DE NONNEVILLE A, Goncalves A, Zemmour C, Cohen M, et al
    Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.
    Eur J Cancer. 2017;84:34-43.
    >> Share

  20. TANG SS, Kaptanis S, Haddow JB, Mondani G, et al
    Current margin practice and effect on re-excision rates following the publication of the SSO-ASTRO consensus and ABS consensus guidelines: a national prospective study of 2858 women undergoing breast-conserving therapy in the UK and Ireland.
    Eur J Cancer. 2017;84:315-324.
    >> Share

  21. STROM T, Harrison LB, Giuliano AR, Schell MJ, et al
    Tumour radiosensitivity is associated with immune activation in solid tumours.
    Eur J Cancer. 2017;84:304-314.
    >> Share

  22. SIMIN J, Tamimi R, Lagergren J, Adami HO, et al
    Menopausal hormone therapy and cancer risk: An overestimated risk?
    Eur J Cancer. 2017;84:60-68.
    >> Share

    Eur Radiol

  23. GIROMETTI R, Zanotel M, Londero V, Linda A, et al
    Automated breast volume scanner (ABVS) in assessing breast cancer size: A comparison with conventional ultrasound and magnetic resonance imaging.
    Eur Radiol. 2017 Oct 10. doi: 10.1007/s00330-017-5074.
    >> Share

    Exp Cell Res

  24. DE S, Das S, Mukherjee S, Das S, et al
    Establishment of Twist-1 and TGFBR2 as direct targets of microRNA-20a in Mesenchymal to Epithelial Transition of Breast Cancer Cell-line MDA-MB-231.
    Exp Cell Res. 2017 Oct 4. pii: S0014-4827(17)30532.
    >> Share


  25. ZHOU L, Gao HF, Liu DS, Feng JY, et al
    Gene expression profiling of brain metastatic cell from triple negative breast cancer: Understanding the molecular events.
    Gene. 2017 Oct 9. pii: S0378-1119(17)30833-8. doi: 10.1016/j.gene.2017.
    >> Share

    Int J Cancer

  26. ZHAO B, Zhao H
    Impact of clinicopathological characteristics on the efficacy of neoadjuvant therapy in patients with human epidermal growth factor receptor-2-positive breast cancer.
    Int J Cancer. 2017 Oct 11. doi: 10.1002/ijc.31097.
    >> Share

  27. CONRAD C, Gotte M, Schlomann U, Roessler M, et al
    ADAM8 expression in breast cancer derived metastases: Functional implications on MMP-9 expression and transendothelial migration in breast cancer cells.
    Int J Cancer. 2017 Oct 7. doi: 10.1002/ijc.31090.
    >> Share

    J Clin Invest

  28. JESCHKE J, Bizet M, Desmedt C, Calonne E, et al
    DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.
    J Clin Invest. 2017;127:3090-3102.
    >> Share

    J Clin Oncol

  29. SHAPIRO CL, Moriarty JP, Dusetzina S, Himelstein AL, et al
    Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance).
    J Clin Oncol. 2017 Oct 12:JCO2017737437. doi: 10.1200/JCO.2017.73.7437.
    >> Share

    J Pathol

  30. LIU J, Ye L, Li Q, Wu X, et al
    Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.
    J Pathol. 2017 Oct 9. doi: 10.1002/path.4995.
    >> Share

    Lancet Oncol

  31. PINEROS M, Ramos W, Antoni S, Abriata G, et al
    Cancer patterns, trends, and transitions in Peru: a regional perspective.
    Lancet Oncol. 2017;18:e573-e586.
    >> Share

  32. GOURD E
    Insulin analog linked to breast cancer risk.
    Lancet Oncol. 2017 Oct 5. pii: S1470-2045(17)30772.
    >> Share

    Nat Rev Clin Oncol

    Breast cancer: LAG3 expression indicates favourable outcomes.
    Nat Rev Clin Oncol. 2017 Oct 10. doi: 10.1038/nrclinonc.2017.
    >> Share


  34. WANG CH, Wang PJ, Hsieh YC, Lo S, et al
    Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    >> Share

    PLoS Comput Biol

  35. SOLER-OLIVA ME, Guerrero-Martinez JA, Bachetti V, Reyes JC, et al
    Analysis of the relationship between coexpression domains and chromatin 3D organization.
    PLoS Comput Biol. 2017;13:e1005708.
    >> Share

    PLoS One

  36. KORKOLA JE, Collisson EA, Heiser LM, Oates C, et al
    Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
    PLoS One. 2017;12:e0186551.
    >> Share

  37. QIAO W, Jia Z, Liu H, Liu Q, et al
    Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
    PLoS One. 2017;12:e0186191.
    >> Share

  38. XIE F, Hosany S, Zhong S, Jiang Y, et al
    MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.
    PLoS One. 2017;12:e0185565.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016